Point72 Asset Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Point72 Asset Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-928,440	Closed	-$49.6M	–	983
2016 Q1	$49.6M	Buy	928,440 +802,940	+640%	+$59.3M	0.38%	56
2015 Q4	$14.2M	Sell	125,500 -25,100	-17%	-$2.77M	0.12%	211
2015 Q3	$17.7M	Buy	150,600 +105,600	+235%	+$13.8M	0.14%	206
2015 Q2	$3.48M	Buy	+45,000	New	+$2.95M	0.02%	506
2015 Q1	–	Sell	-1,564,343	Closed	-$50.5M	–	925
2014 Q4	$50.5M	Buy	1,564,343 +9,743	+0.6%	+$292K	0.35%	85
2014 Q3	$38M	Buy	+1,554,600	New	+$31.6M	0.29%	95

Other funds holding ANAC

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Point72 Asset Management's ANAC Position: Q2 2016 in Review

Point72 Asset Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 928,440 shares — an estimated $49.6M sold.

Point72 Asset Management first reported a position in ANAC in Q3 2014 and held it in 6 quarters. The position peaked at $50.5M in Q4 2014. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Point72 Asset Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Point72 Asset Management sold 928,440 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $49.6M.
Point72 Asset Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2014 and held it in 6 quarters.
Point72 Asset Management's ANACOR PHARMACEUTICALS INC COM position peaked at $50.5M in Q4 2014.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Point72 Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.